Back to search
FDAFDA · Food and drugs·Recall number D-0576-2022

Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-465-62

Published March 2, 2022 · Recall initiated: January 19, 2022

Summary

FDA records drug Class III recall D-0576-2022, published March 2, 2022 and initiated January 19, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 18261 vials; Lot: Lot#: H200107, Exp 8/1/2023; H200154, Exp 9/1/2023; H210020, Exp 11/1/2023; H210055, Exp 12/1/2023; H210129, Exp 1/1/2024, H210288, Exp 4/1/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed stability specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if AZACITIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AZACITIDINE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
USA Nationwide
Lot
Lot#: H200107, Exp 8/1/2023; H200154, Exp 9/1/2023; H210020, Exp 11/1/2023; H210055, Exp 12/1/2023; H210129, Exp 1/1/2024, H210288, Exp 4/1/2024.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-465-62 recalled?

Yes. FDA published recall D-0576-2022 on March 2, 2022. Reported hazard: Failed stability specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AZACITIDINE.